Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BULK DEALS
Bulk Deals      
Sampre Nutritions Ltd.
BSE Code 530617
ISIN Demat INE375C01014
Book Value 45.02
NSE Code NA
Dividend Yield % 0.00
Market Cap 3352.40
P/E 0.00
EPS -3.13
Face Value 10  
 
 
   
Deal DateCompany NameClient NameTranQty.(000's)ValuePriceTrade(Rs.in Lakhs)Close Price
15-Oct-2025 Sampre Nutritions AKARSHIKA TRADERS LLPBUY 443603147.365342721.9153.45
15-Oct-2025 Sampre Nutritions EPITOME TRADING AND INVESTMENTSSELL 160000147.2223555200153.45
15-Oct-2025 Sampre Nutritions GREEN PEAKS ENTERPRISES LLPBUY 115000147.5516968250153.45
15-Oct-2025 Sampre Nutritions GREEN PEAKS ENTERPRISES LLPSELL 196597147.0128901724.97153.45
15-Oct-2025 Sampre Nutritions NEO APEX VENTURE LLPSELL 296269147.1943607834.11153.45
03-Oct-2025 Sampre Nutritions NEO APEX VENTURE LLPSELL 173594126.1521898883.1153.45
01-Oct-2025 Sampre Nutritions NEO APEX VENTURE LLPBUY 108594123.713433077.8153.45
30-Sep-2025 Sampre Nutritions NEO APEX VENTURE LLPBUY 115000121.2813947200153.45
29-Sep-2025 Sampre Nutritions GREEN PEAKS ENTERPRISES LLPBUY 111423118.9113249308.93153.45
29-Sep-2025 Sampre Nutritions GREEN PEAKS ENTERPRISES LLPSELL 55090118.656536428.5153.45
17-Sep-2025 Sampre Nutritions MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBUY 129600101.5113155696153.45
16-Sep-2025 Sampre Nutritions EPITOME TRADING AND INVESTMENTSBUY 11624499.5211568602.88153.45
11-Sep-2025 Sampre Nutritions NEO APEX VENTURE LLPSELL 16000093.7815004800153.45
08-Sep-2025 Sampre Nutritions EPITOME TRADING AND INVESTMENTSBUY 1696088.41499264153.45
08-Sep-2025 Sampre Nutritions EPITOME TRADING AND INVESTMENTSSELL 18000088.315894000153.45
08-Aug-2025 Sampre Nutritions MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 15375960.639322408.17153.45
11-Jul-2025 Sampre Nutritions MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSELL 14556841.075978477.76153.45
11-Jul-2025 Sampre Nutritions NEO APEX VENTURE LLPSELL 16500041.096779850153.45
10-Jul-2025 Sampre Nutritions NEO APEX VENTURE LLPBUY 16500040.36649500153.45
18-Jun-2025 Sampre Nutritions NOVARATHANMALPRAVEENKUMARSELL 12200029.423589240153.45
Page 1 of 6
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.